Long-term cyclosporine treatment: Evaluation of serum biochemical parameters and histopathological alterations in Wistar rats

Experimental and Toxicologic Pathology

Volumn 63, Issue 1-2, 2011, Pages 119-123

  Elisa Böhmer, Ana ^a   Ribeiro Corrĉa, André Mendes ^a   de Souza, Débora Guerini ^a   Knorr, Luisa ^a   Hansel, Gisele ^a   Gustavo Corbellini, Luís ^a   Driemeier, David ^a   Valmor Portela, Luis ^a   Onofre Souza, Diogo ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Adverse effects; Biochemical alterations; Cyclosporine; Histopathological; Interleukins

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CORN OIL; CREATININE; CYCLOSPORIN; GAMMA INTERFERON; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BIOCHEMISTRY; BLOOD ANALYSIS; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; LIVER TOXICITY; LONG TERM CARE; NEPHROTOXICITY; NONHUMAN; RAT;

ANIMALS; CYCLOSPORINE; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY FUNCTION TESTS; LIVER; LIVER FUNCTION TESTS; LUNG; MALE; RATS; RATS, WISTAR; TIME FACTORS;

RATTUS; RATTUS NORVEGICUS; ZEA MAYS;

EID: 78650178347     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etp.2009.10.005     Document Type: Article

References (26)

1. Benigni A., Bruzzi I., Mister M., Azzollini N., Gaspari F., Remuzzi G. Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year. Kidney Int 1999, 55:674-685.
2. Bennett W.M., DeMattos A., Meyer M.M., Andoh T., Barry J.M., et al. Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy. Kidney Int 1996, 50:1089-1100.
3. Blair J.T., Thomson A.W., Whiting P.H., Davidson R.J., Simpson J.G. Toxicity of the immune suppressant cyclosporin A in the rat. J Pathol 1982, 138:163-178.
4. Borel J.F., Baumann G., Chapman I., Donatsch P., Fahr A., Mueller E.A., et al. In vivo pharmacological effects of ciclosporin and some analogues. Adv Pharmacol 1996, 35:115-246.
5. Cattaneo D., Perico N., Remuzzi G. Functional loss of the transplanted kidney: immunological and non-immunological factors. G Ital Nefrol 2004, 21(Suppl. 26):S28-33.
6. Dahm LJ, Jones DP. Textbook of liver disease: mechanisms of chemically induced liver disease. In: Zakim D, Boyer TD, editors, Hepatology. Philadelphia: WBS 1996, p. 875-90.
7. Diao T.J., Yuan T.Y., Li Y.L. Immunologic role of nitric oxide in acute rejection of golden hamster to rat liver xenotransplantation. World J Gastroenterol 2002, 8:746-751.
8. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood 1996, 87:2095-2147.
9. Grub S., Persohn E., Trommer W.E., Wolf A. Induction of apoptosis by the O-hydroxyethyl-d(Ser)(8)-cyclosporine A derivative SDZ IMM 125 in rat hepatocytes. J Pharmacol Exp Ther 2000, 293:24-32.
10. Grub S., Persohn E., Trommer W.E., Wolf A. Mechanisms of cyclosporine A-induced apoptosis in rat hepatocyte primary cultures. Toxicol Appl Pharmacol 2000, 163:209-220.
11. Ho S., Clipstone N., Timmermann L., Northrop J., Graef I., Fiorentino D., et al. The mechanism of action of cyclosporin A and FK506. Clin Immunol Immunopathol 1996, 80:S40-5.
12. Kurus M., Esrefoglu M., Karabulut A.B., Sogutlu G., Kaya M., Otlu A. Oral l-arginine protects against cyclosporine-induced hepatotoxicity in rats. Exp Toxicol Pathol 2008, 60:411-419.
13. Linde T., Sandhagen B., Backman U., Fellstrom B. Altered flow properties of blood and increased plasma fibrinogen in cyclosporin-treated renal allograft recipients. Nephrol Dial Transplant 1999, 14:1525-1529.
14. Myers B.D., Ross J., Newton L., Luetscher J., Perlroth M. Cyclosporine-associated chronic nephropathy. N Engl J Med 1984, 311:699-705.
15. Nelson B.H. Interleukin-2 signaling and the maintenance of self-tolerance. Curr Dir Autoimmun 2002, 5:92-112.
16. Pazetti, R, Pego-Fernandes, PM, Lorenzi-Filho, G, Saldiva, PH, Moreira, LF, Jatene, FB. Effects of cyclosporine A and bronchial transection on mucociliary transport in rats. Ann Thorac Surg 2008;85:1925-9; [discussion 1929].
17. Ryffel B., Donatsch P., Madorin M., Matter B.E., Ruttimann G., Schon H., et al. Toxicological evaluation of cyclosporin A. Arch Toxicol 1983, 53:107-141.
18. Sebastian MM, Baskin SI, Czerwinski SE. Textbook of toxicology basic and clinical principles: renal toxicity. In: Gupta RC, editor, Veterinary Toxicology: Basic & Clinical Principles. New York, London: Academic, E, Press; 2007, p. 161-76.
19. Shihab F.S., Andoh T.F., Tanner A.M., Noble N.A., Border W.A., Franceschini N., et al. Role of transforming growth factor-beta 1 in experimental chronic cyclosporine nephropathy. Kidney Int 1996, 49:1141-1151.
20. Taylor A.L., Watson C.J., Bradley J.A. Immunosuppressive agents in solid organ transplantation: mechanisms of action and therapeutic efficacy. Crit Rev Oncol Hematol 2005, 56:23-46.
21. Thomson A.W., Whiting P.H., Blair J.T., Davidson R.J., Simpson J.G. Pathological changes developing in the rat during a 3-week course of high dosage cyclosporin A and their reversal following drug withdrawal. Transplantation 1981, 32:271-277.
22. Thomson A.W., Whiting P.H., Simpson J.G. Cyclosporine: immunology, toxicity and pharmacology in experimental animals. Agents Actions 1984, 15:306-327.
23. Van Damme J., Cayphas S., Van Snick J., Conings R., Put W., Lenaerts J.P., et al. Purification and characterization of human fibroblast-derived hybridoma growth factor identical to T-cell-derived B-cell stimulatory factor-2 (interleukin-6). Eur J Biochem 1987, 168:543-550.
24. Vercauteren S.B., Bosmans J.L., Elseviers M.M., Verpooten G.A., De Broe M.E. A meta-analysis and morphological review of cyclosporine-induced nephrotoxicity in auto-immune diseases. Kidney Int 1998, 54:536-545.
25. Wolf A., Trendelenburg C.F., Diez-Fernandez C., Prieto P., Houy S., Trommer W.E., et al. Cyclosporine A-induced oxidative stress in rat hepatocytes. J Pharmacol Exp Ther 1997, 280:1328-1334.
26. Zhang X., Chen B.C., Xiang F.L., Chang S., Zhou H.M., Du D.F., et al. Inhibition of MD-1 expression by immunosuppressants or antisense oligodeoxynucleotides on skin allograft survival in mice. Transplant Proc 2005, 37:1965-1967.